| Name | Title | Contact Details |
|---|
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.
Oxford Health Plans, Inc. is a healthcare company providing health benefit plans primarily in New York, New Jersey and Connecticut. Its product line includes its health maintenance organization plans, exclusive provider organization plans,
Seagrove Inc. is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vial is a leading clinical trial site network that runs highly efficient clinical trials. Vial operates a network of clinical trial research sites within Dermatology clinics across the country. Vials clinical trial recruiting engine, software and oper...
CeloNova BioSciences, Inc. is a Peachtree City, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.